Novoic
					Novoic analyzes patient speech patterns with AI to identify early signs of Alzheimer’s and other neurodegenerative conditions. Its assessments integrate into clinical workflows—enabling objective, preclinical screening and monitoring.
Founders
Emil Fristed
Cofounder
Emil graduated with distinction from the University of Oxford with a Master’s in Neuroscience. He worked in a world-leading auditory neuroscience group (King Group), applying machine learning models to understand the senses; he studied language and how it changes as the brain gets ill. Prior to that he completed a Bachelor’s degree in Molecular Medicine, graduating at the top of his class, and was selected to undertake an independent research project in Alzheimer’s disease during his studies.
Jack Anthony Weston
CTO
Jack obtained a PhD in Particle Physics from the University of Cambridge, and a Master of Physics from the University of Oxford. He spent time as a professor at the University of Oxford and is also a research fellow at the Cambridge Institute for Theoretical Cosmology.